Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

This is a phase II randomized controlled clinical trial to assess the toxicities and clinical efficacy of prostate specific membrane antigen (PSMA) positron emission tomography / computed tomography (PET/CT) and multi- parameter Magnetic Resonance Imaging (MRI) guided simultaneous integrated boost for prostate cancer.

Trial Details

NCT ID
NCT05010343
Phase
PHASE2
Sponsor
Shanghai Proton and Heavy Ion Center
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • carbon ion irradation
  • Carbon Ion Irradiation With SIB
Locations (sample)
  • Shanghai, China|31.22222,121.45806

Key Eligibility Criteria

  • Pathologically confirmed adenocarcinoma of prostate
  • Stage cT1-3N0M0 localized prostate cancer
  • performed PSMA PET/CT and mpMRI before treatment
  • No lymph nodes or distant metastasis

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →